Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Entelo Bio logo — The human data engine for strength, repair, and mobility

Entelo Bio

The human data engine for strength, repair, and mobility

Founded 2023 United Kingdom London, United Kingdom 14 employees Biopharma, Biotechnology

General Information

Company Name Entelo Bio
Founded Year 2023
Location United Kingdom London, United Kingdom
Employees 14
Industries Biopharma, Biotechnology
Social

BounceWatch is an independent company data service, not affiliated with Entelo Bio. To contact Entelo Bio, visit entelo.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Entelo Bio

Entelo Bio is a biopharma and biotechnology company based in London, United Kingdom. They focus on decoding complex conditions related to human resilience, particularly targeting muscle health.

Founded in 2023, Entelo Bio specializes in functional genomics, computational biology, and precision medicine. The company utilizes single-cell genomics, RNA biology, and dark RNA to aid in target and isoform discovery. Their platform is designed to monetize by providing measurable and treatable solutions for human resilience as healthcare trends toward direct-to-consumer models.

Taxonomy: functional genomics, computational biology, precision medicine, single-cell genomics, RNA biology, dark RNA, target discovery, isoform discovery, functional cell profiling, novel target discovery

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Spinout Undisclosed 2
The University of Oxford
The University of Oxford, Oxford University Innovation
01 Jan 2022

Entelo Bio Alternatives & Competitors

Entelo Bio vs
The Bioinformatics CRO
The Bioinformatics CRO United States

Done Right, Now

18 employees
Biopharma, Biotechnology
Entelo Bio vs
Moonwalk Biosciences
Moonwalk Biosciences United States

Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and epigenetic i...

Series A
21 employees
AI, Biopharma
Entelo Bio vs
64x Bio
64x Bio United States

Enabling next generation medicines.

Series A
21 employees
Biopharma, Biotechnology

FAQ About Entelo Bio

The human data engine for strength, repair, and mobility
Entelo Bio was founded in 2023.
Entelo Bio is headquartered in London, United Kingdom.
Entelo Bio operates in Biopharma and Biotechnology. Its work centres on functional genomics, computational biology, precision medicine and single-cell genomics.
Entelo Bio has approximately 14 employees.
Entelo Bio has completed 1 funding round.
Top alternatives and competitors to Entelo Bio include The Bioinformatics CRO, Moonwalk Biosciences, 64x Bio, CLOVERNA, FogPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Entelo Bio and The Bioinformatics CRO are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Entelo Bio, https://bouncewatch.com/company/caeruleus-genomics, updated 29 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes